I was in notified by the same insurance company, Blue Cross and Blue Shield of Minnesota that the patient has to fail thalidomide first before receiving Len. So I am now in the year 2002 please RT this so executives at Blue Cross and Blue Shield. See what a bunch of morons they R
My patient with high risk multiple myeloma and cardiac amyloidosis received Dara CyBord had a short-lived response and relapsed. I attempted to begin the process for CAR-T and was notified by Blue Cross Blue Shield of Minnesota that the patient has to fail lenalidomide first.. 👇
We look forward to learning from Dr. Daniel Polsky at today’s Grand Rounds. Dr. Polsky joins us from @JHU_BDPs, @JohnsHopkinsSPH, and @JHUCarey: https://t.co/9pFbkv0RhN
Opioid agonist treatment (OAT) can improve HIV outcomes for people with opioid use disorder. In @AIDS_Journal, @CzarinaBehrends and @BruceSchackman explain the urgent need to evaluate the true cost of providing OAT around the world: https://t.co/Ln3lwCu1OA
Both high and increasing addictive screen use trajectories were associated with suicidal behaviors, suicidal ideation, and worse mental health in US youths.
https://t.co/OBeXO7yq39 @YunyuXiaoPhD
JCOIN is accepting applications for the Rapid Innovation Grant (J-RIG), offering up to $135K for short-term projects addressing addiction and overdose in criminal legal populations. Apply by August 31, 2025: https://t.co/XcIK4oNy6r
We are pleased to announce the 2025-2026 CHERISH pilot grant recipients! Continue to our site to learn about their research identifying opportunities and challenges in delivering substance use and HCV/HIV care to rural and high-risk populations: https://t.co/xW6vPSxsFs
JAMA Pediatrics is offering a 2-year editorial fellowship position for a qualified individual who will be supported with a small stipend. Read this Call for Applications to learn more. https://t.co/H8yFJm34nb
A new study in @JAMAHealthForum from Dr. Angelica Meinhofer and colleagues finds that state school Medicaid expansions led to increased access to Medicaid-funded school-based health services for children who have experienced parental opioid use disorder: https://t.co/h2iuRCsSGn
Manuscripts showcasing novel strategies to engage individuals in treatment, address structural barriers, and promote equity in access to care are especially welcome. Learn more here: https://t.co/yue9LOhJb6
Good news! My article on Waldenstroms had enough citations to be a Top Cited Article. Read it here https://t.co/0kUTgO9rum #TopCitedArticle@wileyinresearch
📅 Join us tomorrow, April 8, as Andrea Jakubowski of @MontefioreDGIM discusses improving access to buprenorphine for opioid use disorder. Learn about low-threshold programs and her latest research!
Become a #PSMG member: https://t.co/snEn3JDnLW!
We’re accepting applications for the C-DIAS Fellowship in Addiction D&I Science! This one-year, mostly virtual program offers mentoring, networking & more. Apply by April 15, 2025!
Learn more: https://t.co/pY8APT35Qu #AddictionScience#PublicHealth#Fellowship
Coming up! Join us 2/11 with Dr. Hansel Tookes for this timely session.
✨ How can we advance the health of PWUD in diverse political contexts?
✨ How do we leverage SSPs to bring comprehensive HIV care to PWUD?
✨ How can we champion harm reduction approaches?